GlassScriptPhysician profile
Richele Shuler
NPI 1629692033
$5,784.13
in general payments reported to CMS, 2019-2025
22 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,513 · 2022: $1,388 · 2023: $2,170 · 2024: $197 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,480 · Food and Beverage: $1,403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,479.57 |
| Food and Beverage | $1,403.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $2,499.58 | 2021-2024 | Urolift |
| Medtronic, INC. | $1,870.29 | 2021-2023 | Interstim |
| Astellas Pharma US INC | $296.16 | 2021-2024 | Xtandi |
| Inspire Medical Systems, INC. | $250.91 | 2025 | Inspire |
| Genzyme Corporation | $193.96 | 2025 | |
| 180 Medical, INC. | $138.75 | 2021-2024 | Gentlecath |
| Abbvie INC. | $67.90 | 2022-2024 | |
| Convatec INC. | $63.41 | 2021-2023 | |
| Smith+Nephew, INC. | $58.54 | 2025 | Tula |
| Axonics, INC. | $57.75 | 2023-2024 | Axonics, Bulkamid |
| Coloplast Corp | $54.87 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $32.79 | 2022-2023 | Lynparza |
| Sumitomo Pharma America, INC. | $27.57 | 2024 | Gemtesa |
| Boston Scientific Corporation | $27.51 | 2021 | |
| Hollister Incorporated | $24.61 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $22.03 | 2024 | Adstiladrin |
| Urovant Sciences INC | $21.31 | 2021 | |
| Blue Earth Diagnostics | $20.61 | 2021 | |
| Myovant Sciences INC. | $16.50 | 2021 | |
| Progenics Pharmaceuticals, INC. | $13.15 | 2023 | Pylarify |
| Myriad Genetic Laboratories, INC. | $13.03 | 2023 | Prolaris |
| 3b Medical, INC. | $12.90 | 2025 | Luna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richele Shuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.